Community-based study of atrial fibrillation and stroke prevention

Irish Medical Journal

Volumn 97, Issue 1, 2004, Pages 10-12

  White, S ^a   Feely, J ^b   O'Neill, Des ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIGOXIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CEREBROVASCULAR ACCIDENT; COMMUNITY CARE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; GENERAL PRACTICE; HEART ATRIUM FIBRILLATION; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL SERVICE; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; TREATMENT CONTRAINDICATION; CLINICAL COMPETENCE; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; EPIDEMIOLOGY; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; OUTCOME ASSESSMENT; RISK ASSESSMENT; STANDARD; STATISTICS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; ATTITUDE OF HEALTH PERSONNEL; CEREBROVASCULAR ACCIDENT; CLINICAL COMPETENCE; COHORT STUDIES; COMMUNITY HEALTH SERVICES; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; IRELAND; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RISK ASSESSMENT; WARFARIN;

EID: 1842840856     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and stroke risk: the Framingham study. Neurology 1978; 28: 973-7
2. Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM. Influence of etilogy of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 1977; 40: 509-513
3. Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton JD. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984; 41: 708-10
4. Harrison MJ, Marshall J. Atrial fibrillation, TIAs and completed strokes. Stroke 1984; 15: 441-2
5. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-73
6. Apleyard M, ed. Copenhagen Heart Study. Scand J Soc Med 1987; 17(suppl): 124-5
7. Hill JD, Mottram EM, Killeen PD. Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age. J R Coll Gen Pract 1987; 37: 172-73
8. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-88
9. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989; 1: 175-9
10. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
11. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-55
12. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Patient characteristics and final results. Circulation 1991; 84: 527-39
13. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687-91
14. European Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-62
15. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327: 1406-12.
16. Sixth American College of Chest Physicians Consensus Conference on Antithrombotic Therapy. Antithrombotic therapy in atrial fibrillation. Chest 2001 Jan;119(1 Suppl):194S-206S
17. Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke 1997; 28: 2382-9
18. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulation in the community. Lancet 1998:352: 1167-71
19. Lawson F, McAlister F, Ackman M, Ikuta R, Montague T. The utilisation of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital. JAGS 1996; 44: 708-11
20. Whittle J, Wickenheiser L, Venditti LN. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? Arch Intern Med 1997; 157: 441-5
21. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997; 314: 1529-30.
22. Stroke Prevention in Atrial Fibrillation Investigators. Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279: 1273-7
23. Landefeld CS et al. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989; 87: 144-52
24. Green CJ et al. Anticaogulants in chronic non-valvular atrial fibrillation: a critical appraisal and meta-analysis. Can J Cardiol 1997; 13:811-5
25. Thomson R, Robinson A, Greenaway J, Lowe P. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Saf Health Care. 2002 Mar;11(1):25-31.
26. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract. 2002 May;52(478):373-4, 377-80.